21 CFR 26, Subpart B - Specific Sector Provisions for Medical Devices
- § 26.31 — Purpose.
- § 26.32 — Scope.
- § 26.33 — Product coverage.
- § 26.34 — Regulatory authorities.
- § 26.35 — Length and purpose of transition period.
- § 26.36 — Listing of CAB's.
- § 26.37 — Confidence building activities.
- § 26.38 — Other transition period activities.
- § 26.39 — Equivalence assessment.
- § 26.40 — Start of the operational period.
- § 26.41 — Exchange and endorsement of quality system evaluation reports.
- § 26.42 — Exchange and endorsement of product evaluation reports.
- § 26.43 — Transmission of quality system evaluation reports.
- § 26.44 — Transmission of product evaluation reports.
- § 26.45 — Monitoring continued equivalence.
- § 26.46 — Listing of additional CAB's.
- § 26.47 — Role and composition of the Joint Sectoral Committee.
- § 26.48 — Harmonization.
- § 26.49 — Regulatory cooperation.
- § 26.50 — Alert system and exchange of postmarket vigilance reports.
- Appendix A to Subpart B of Part 26 - Relevant Legislation, Regulations, and Procedures
- Appendix B to Subpart B of Part 26 - Scope of Product Coverage
- Appendices C-F to Subpart B of Part 26 [Reserved]
Title 21 published on 2012-04-01
no entries appear in the Federal Register after this date.
This is a list of United States Code sections, Statutes at Large, Public Laws, and Presidential Documents, which provide rulemaking authority for this CFR Part.
This list is taken from the Parallel Table of Authorities and Rules provided by GPO [Government Printing Office].
It is not guaranteed to be accurate or up-to-date, though we do refresh the database weekly. More limitations on accuracy are described at the GPO site.
- Appendix A to Subpart B of Part 26 - Relevant Legislation, Regulations, and Procedures
- Appendix B to Subpart B of Part 26 - Scope of Product Coverage
- Appendices C-F to Subpart B of Part 26 [Reserved]
